InvestorsObserver
×
News Home

Does Rigel Pharmaceuticals Inc (RIGL) Have What it Takes to be in Your Portfolio Friday?

Friday, January 27, 2023 11:41 AM | InvestorsObserver Analysts

Mentioned in this article

Does Rigel Pharmaceuticals Inc (RIGL) Have What it Takes to be in Your Portfolio Friday?

Rigel Pharmaceuticals Inc (RIGL) is around the top of the Biotechnology industry according to InvestorsObserver. RIGL received an overall rating of 79, which means that it scores higher than 79 percent of all stocks. Rigel Pharmaceuticals Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 37 out of the 148 industries.

Overall Score - 79
RIGL has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on RIGL!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Rigel Pharmaceuticals Inc Stock Today?

Rigel Pharmaceuticals Inc (RIGL) stock is lower by -4.78% while the S&P 500 has risen 0.18% as of 11:41 AM on Friday, Jan 27. RIGL has fallen -$0.09 from the previous closing price of $1.87 on volume of 1,359,019 shares. Over the past year the S&P 500 is lower by -5.98% while RIGL has fallen -22.94%. RIGL lost -$0.48 per share the over the last 12 months. Click Here to get the full Stock Report for Rigel Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App